1
![Epizyme]()
![Epizyme]()
![Epizyme]()
Epizyme
Leadership team
Yi Zhang (Founder)
Robert Horvitz (Founder)
Products/ Services
Biopharma, Biotechnology, Health Care
Number of Employees
100 - 500
Headquarters
Cambridge, Massachusetts, United States
Established
2007
Company Registration
SEC CIK number: 0001571498
Traded as
NASDAQ:EPZM
Overview
Location
Summary
Epizyme, Inc. is a biopharmaceutical company creating novel epigenetic therapies for cancers and other diseases with high unmet medical need.
History
Epizyme was founded in 2007 by three leading pioneers in epigenetics research – Troy Australia, Gregory Verdeil, and Craig Thompson. The core team consists of leading researchers, developers, and expert advisors in the areas of oncology, rare diseases and diseases of the central nervous system.
Mission
Epizyme is dedicated to improving the lives of people affected by cancer, and other serious diseases. We believe in the promise of epigenetics to drive the development of novel treatments to improve the futures of those afflicted by these debilitating illnesses.
Vision
Our vision is to create an even more personalized approach to treatment of diseases, providing life-saving therapies that are tailored to individual circumstances, based on a detailed understanding of the epigenetics driving their disease.
Key Team
Robert Horvitz (Founder)
Yi Zhang (Founder)
Recognition and Awards
Recognized and respected for our work, Epizyme has been awarded numerous awards, such as the 2015 Nature Biotech Breakthroughs of the Year, the 2014 Technology and Engineering Award from Frost and Sullivan, and the 2014 Breakthrough prizefrom the Society for Industrial and Organizational Psychology.
References
Dive deeper into fresh insights across Business, Industry Leaders and Influencers, Organizations, Education, and Investors for a comprehensive view.
Leadership team
Yi Zhang (Founder)
Robert Horvitz (Founder)
Products/ Services
Biopharma, Biotechnology, Health Care
Number of Employees
100 - 500
Headquarters
Cambridge, Massachusetts, United States
Established
2007
Company Registration
SEC CIK number: 0001571498
Traded as
NASDAQ:EPZM